je.st
news
German drugmaker Merck sees Q4 net more than double to $355 million
2013-03-07 10:02:15| Biotech - Topix.net
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Tags: to
net
double
million
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||